SCHEMBL2534812

SCHEMBL2534812

COC(=O)c1ccc(F)c2c1CC(C)(C)C(c1cccc(N3CCOCC3)c1)N2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SETD2 Q9BYW2 1/20 0.40
CYP2C19 P33261 1/20 0.40
ALOX15 P16050 3/20 0.37
GAA P10253 2/20 0.37
MAPK1 P28482 2/20 0.37
ALDH1A1 P00352 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MAPK9 P45984 1/20 0.37
MAPK10 P53779 1/20 0.37
PRKDC P78527 1/20 0.36
FAAH O00519 1/20 0.36
MRGPRX4 Q96LA9 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAPT P10636 3/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2530149 0.90 CYP2C19 (0.43) SETD2CYP2C19GAAALDH1A1PRKDC
SCHEMBL2534808 0.90 CYP2C19 (0.40) CYP2C19ALOX15GAAMAPK1ALDH1A1
SCHEMBL14331256 0.90 CYP2C19 (0.41) SETD2CYP2C19MAPK9MAPK10PRKDC
SCHEMBL2537468 0.86 CYP2C19 (0.40) SETD2CYP2C19ALOX15GAAMAPK1
SCHEMBL2531707 0.85 SETD2 (0.39) SETD2CYP2C19MAPK9MAPK10PRKDC
SCHEMBL2529295 0.84 CYP2C19 (0.40) SETD2CYP2C19ALOX15GAAMAPK1
SCHEMBL2531392 0.84 SETD2 (0.40) SETD2CYP2C19ALOX15MAPK1ALDH1A1
SCHEMBL2533037 0.83 CYP2C19 (0.40) CYP2C19ALOX15GAAMAPK1ALDH1A1
SCHEMBL2535676 0.83 KDM1A (0.40) CYP2C19ALOX15GAAMAPK1ALDH1A1
SCHEMBL2535474 0.82 TSHR (0.39) ALDH1A1HSD17B10MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2558449-B1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-05 EP disclosed
US-8586747-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2013-11-19 US disclosed
EP-2558449-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2013-02-20 EP disclosed
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES Hoffmann-La Roche Inc (US) 2013-01-24 US disclosed
US-8344137-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMAN-LA ROCHE INC. (US) 2013-01-01 US disclosed
WO-2011128251-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2011-10-20 WO disclosed
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HUA MEDICINE (KY) 2011-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 SETD2 436/4885CYP2C19 273/4885ALOX15 3749/4885
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 SETD2 436/4885CYP2C19 273/4885ALOX15 3749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.